McLean 2017.
Study name | Design of a randomized controlled trial examining the efficacy and biological mechanisms of web‐prolonged exposure and present‐centered therapy for PTSD among active‐duty military personnel and veterans. |
Methods | Randomised controlled trial |
Participants | 120 Participants are active duty military personnel stationed at Fort Hood, TX, and veterans in the surrounding area who have deployed since 11 September 2001, who are seeking treatment for PTSD, aged 18–65 years. Up to 170 people will be consented and screened to obtain data for analysis from 120 participants (60 participants in each treatment condition). Inclusion criteria
Exclusion criteria
Concomitant medications are not exclusionary; all medication changes are monitored for the duration of the trial. |
Interventions | Web PE versus PCT |
Outcomes | Time point for assessment: baseline, post‐treatment, 3‐month follow‐up, and 6‐month follow‐up. Primary outcome: PTSD severity, as measured by CAPS‐5, a structured diagnostic interview that assesses DSM‐5 criteria for PTSD and yields information about PTSD symptom severity and PTSD diagnostic status. Secondary measures include: AUDIT; CEQ; CTQ; DSI‐SS; GAD‐7; ISI; LEC; MINI‐7.0; PCL‐5, 1‐month and 2‐week versions; PHQ‐9; PHQ‐15; PTCI; PWPQ (based on the Perceptions of Computerized Therapy Questionnaire); STAXI‐2; VR‐12 |
Starting date | Unknown |
Contact information | Carmen P McLean Stanford University School of Medicine mcleanca@pennmedicine.upenn.edu |
Notes |